Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients (Q73051788)
Jump to navigation
Jump to search
scientific article published on 01 October 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients |
scientific article published on 01 October 2000 |
Statements
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients (English)
Y Hamada
J Nakamura
K Naruse
T Komori
K Kato
Y Kasuya
R Nagai
S Horiuchi
1 October 2000